August 18, 2025

FDA Approves New Indication for Wegovy

Accelerated approval granted to Wegovy for treatment of noncirrhotic metabolic dysfunction–associated steatohepatitis in adults with stage F2 to F3 fibrosis.

Conexiant

August 18, 2025

Societies Issue Joint Updates to Hypertension Guidelines

A central update is the recommendation for use of the PREVENT calculator to help determine risk.

Conexiant

August 18, 2025

Health Groups Respond to 'National Scandal'

With elder homelessness rising, PACE programs funded by Medicaid and Medicare secure housing and health care for low-income seniors, seen in Rhode Island.

KFF Health News

August 18, 2025

'Social Apnea' Highest on Saturdays

Weekend catch-up sleep and social jetlag may increase obstructive sleep apnea severity.

Conexiant

August 14, 2025

Greater Variety of Flavonoids Tied to Lower Chronic Disease

Higher diversity and quantity of dietary flavonoid intake were each linked to reduced risks of mortality and major chronic diseases in a large population-based study.

Conexiant

August 07, 2025

Every 1,000 Steps May Slash Heart Risk 17%

Each additional 1,000 daily steps a day may be associated with a reduction in major adverse cardiovascular events among patients with hypertension, with benefits evident at step counts well below 10,000 steps per day.

Conexiant

August 07, 2025

Delayed Hypertension Diagnoses Raise 5-Year Cardiovascular Risk

Analysis of electronic health records reveals that delays in clinical hypertension diagnosis persist despite frequent outpatient visits and are linked to increased cardiovascular event rates.

Conexiant

August 01, 2025

Consistent or Increasing Physical Activity Across Adulthood Linked to Lower Mortality

This large meta-analysis on physical activity patterns and mortality—encompassing 85 prospective cohort studies—shows that consistent or increasing physical activity during adulthood is associated with lower all-cause and cardiovascular mortality risk.

Conexiant

July 30, 2025

JAK Inhibitors May Improve Artery Health Markers

JAK inhibitor therapy targets inflammation and correlates with improvements in carotid artery measurements, while baseline vascular markers continue to predict cardiovascular risk.

Conexiant